CN101095701A - 一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法 - Google Patents
一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法 Download PDFInfo
- Publication number
- CN101095701A CN101095701A CNA2007100153844A CN200710015384A CN101095701A CN 101095701 A CN101095701 A CN 101095701A CN A2007100153844 A CNA2007100153844 A CN A2007100153844A CN 200710015384 A CN200710015384 A CN 200710015384A CN 101095701 A CN101095701 A CN 101095701A
- Authority
- CN
- China
- Prior art keywords
- agent
- shen
- powder
- medicine
- fermented cordyceps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 39
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 241000143459 Hirsutella Species 0.000 title claims description 33
- 241000190633 Cordyceps Species 0.000 title claims description 22
- 238000000034 method Methods 0.000 title abstract description 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 13
- 239000008187 granular material Substances 0.000 claims abstract description 11
- 239000000314 lubricant Substances 0.000 claims abstract description 10
- 239000000080 wetting agent Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000012856 packing Methods 0.000 claims abstract description 5
- 229920002472 Starch Polymers 0.000 claims description 12
- 239000011230 binding agent Substances 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- -1 hydroxypropyl Chemical group 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims description 6
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 6
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 2
- 229940037627 magnesium lauryl sulfate Drugs 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 abstract description 14
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 230000000638 stimulation Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 3
- 239000000853 adhesive Substances 0.000 abstract 3
- 241000130660 Hepialidae Species 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 1
- 230000010354 integration Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明属于一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法。所要解决的问题就是背景技术存在的：服用此种药物胶囊制剂胃部不适；不适合老人等人群服用；胶囊中药物的粒度相对较大，不利于功效成份的吸收。解决该技术问题所采用的技术方案要点是：其含有主料：蝙蝠蛾被毛孢-发酵虫草菌粉；辅料：湿润剂和/或粘合剂、崩解剂、润滑剂。取蝙蝠蛾被毛孢菌丝，粉碎成极细粉，取极细粉333g，加入湿润剂和/或粘合剂30-40g、崩解剂20-30g，混合均匀，加入浓度10-15％的粘合剂溶液进行调和，制粒，80℃以下干燥，整粒，加入崩解剂25-35g，润滑剂10-20g、混匀，压制成1000片，包装，即得。本发明具有性状稳定、剂量准确，成本低，无不良刺激、对药物的吸收更易等优点。
Description
技术领域：本发明属于“冬虫夏草”类的药品及其制备方法，特别是一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法。
背景技术：蝙蝠蛾被毛孢菌粉，是从青海新鲜“冬虫夏草”中分离得到的麦角菌科真菌冬虫夏草的无性世代——蝙蝠蛾被毛孢菌种，经液体发酵培养所得菌丝体的干燥粉末。是天然“冬虫夏草”人工替代品。具有“补肺益肾，止血化痰功能。用于久咳虚喘，劳嗽咯血，阳痿遗精，腰膝酸痛”。现代医学发现，还具有镇静、抗惊厥、降压、改善心肌缺血、抗衰老、提高免疫力、双向调节人体内分泌、抗排异和抗肺癌、淋巴癌、肝癌的作用，其药用价值越来越引起国内外药学界的重视。目前市场上含有蝙蝠蛾被毛孢菌粉的药品仅有一种胶囊制剂，制剂法定名“百令胶囊”，是将蝙蝠蛾被毛孢菌丝经一般方法粉碎后直接填充至胶囊壳中，其对蝙蝠蛾被毛孢菌丝粉碎的粒度无特殊要求。其主要缺陷是：1、服用此种药物在发挥蝙蝠蛾被毛孢菌粉治疗作用的同时又服用了胶囊壳，而胶囊壳主要是由明胶加填充剂和色素制成，由于胶囊壳的存在有些患者在服用后会感到胃部不适；2、胶囊药物不适合老人、儿童及吞咽动作不协调的人群服用；3、由于胶囊制剂的内容物蝙蝠蛾被毛孢菌粉是用一般方法粉碎的，胶囊中药物的粒度相对较大，一般为60-80目，在人体中不利于功效成份的吸收与利用，不利于充分发挥其应有的治疗作用。
发明内容：本发明的目的就是提出一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法的技术方案，以解决背景技术存在的：服用此种药物在发挥蝙蝠蛾被毛孢菌粉治疗作用的同时又服用了胶囊壳，存在有些患者在服用后会感到胃部不适；胶囊药物不适合老人、儿童及吞咽动作不协调的人群服用；胶囊中药物的粒度相对较大，在人体中不利于功效成份的吸收与利用，不利于充分发挥其应有的治疗作用。解决该技术问题所采用的技术方案是：一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品，其特征在于其含有主料：蝙蝠蛾被毛孢-发酵虫草菌粉；辅料：湿润剂和/或粘合剂、崩解剂、润滑剂；其中，按照每333g蝙蝠蛾被毛孢-发酵虫草菌粉，配合30-40g湿润剂和/或粘合剂，45-65g崩解剂，10-20g润滑剂。其中，辅料中的湿润剂和/或粘合剂为：交联聚维酮、羟丙基甲基纤维素、糊精、微晶纤维素、蒸馏水、乙醇、淀粉浆、羧甲基纤维素钠、羟丙基纤维素、甲基纤维素、乙基纤维素、明胶、蔗糖、聚乙烯吡咯烷酮；崩解剂为：羧甲基淀粉钠、干淀粉、低取代羟丙基纤维素、交联聚乙烯吡咯烷酮、交联羧甲基纤维素钠；润滑剂为：微粉硅胶、硬脂酸镁、滑石粉、氢化植物油、聚乙二醇类、月桂醇硫酸镁。一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品(如前所述)的制备方法，其特征在于取蝙蝠蛾被毛孢菌丝，粉碎成极细粉，取极细粉333g，加入湿润剂和/或粘合剂30-40g、崩解剂20-30g，混合均匀，加入浓度10-15％的粘合剂溶液进行调和，制粒，80℃以下干燥，整粒，加入崩解剂25-35g，润滑剂10-20g、混匀，压制成1000片，包装，即得。
本发明与现有技术比较所具有的有益效果是：由于采用上述技术方案，1、本药品生产的机械化、自动化程度较高，性状稳定、剂量准确，成本及售价都较低，其运输、贮存、携带及应用也都比较方便。2、本药品无胶囊壳对胃造成的不良刺激。3、本药品中对主料蝙蝠蛾被毛孢菌丝粉碎成极细粉，粒度在150目以上，使蝙蝠蛾被毛孢菌丝的细胞破壁率大大提高，服用时在人体内的生物利用度较高，使人体对药物的吸收更易、更充分。
具体实施方式：。
实施例1、一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品，其含有主料：蝙蝠蛾被毛孢-发酵虫草菌粉333g；辅料：交联聚维酮、羟丙基甲基纤维素、糊精、微晶纤维素的混合物40g、55g羧甲基淀粉钠、20g微粉硅胶。
一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品(如上所述)的制备方法，其特征在于取蝙蝠蛾被毛孢菌丝，粉碎成极细粉，取极细粉333g，加入交联聚维酮、羟丙基甲基纤维素、糊精、微晶纤维素的混合物40g、羧甲基淀粉钠20g，混合均匀，加入浓度15％的粘合剂溶液进行调和，制粒，80℃以下干燥，整粒，加入羧甲基淀粉钠35g，微粉硅胶20g、混匀，压制成1000片，包装，即得。
实施例2、一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品，其含有主料：蝙蝠蛾被毛孢-发酵虫草菌粉333g；辅料：交联聚维酮、羟丙基甲基纤维素、糊精、微晶纤维素的混合物35g、60g羧甲基淀粉钠、15g微粉硅胶。
一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品(如上所述)的制备方法，其特征在于取蝙蝠蛾被毛孢菌丝，粉碎成极细粉，取极细粉333g，加入交联聚维酮、羟丙基甲基纤维素、糊精、微晶纤维素的混合物35g、羧甲基淀粉钠30g，混合均匀，加入浓度12％的粘合剂溶液进行调和，制粒，80℃以下干燥，整粒，加入羧甲基淀粉钠30g，微粉硅胶15g、混匀，压制成1000片，包装，即得。
Claims (3)
1、一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品，其特征在于其含有主料：蝙蝠蛾被毛孢-发酵虫草菌粉；辅料：湿润剂和/或粘合剂、崩解剂、润滑剂；其中，按照每333g蝙蝠蛾被毛孢-发酵虫草菌粉，配合30-40g湿润剂和/或粘合剂，45-65g崩解剂，10-20g润滑剂。
2、根据权利要求1所述一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品，其特征在于辅料中的湿润剂和/或粘合剂为：交联聚维酮、羟丙基甲基纤维素、糊精、微晶纤维素、蒸馏水、乙醇、淀粉浆、羧甲基纤维素钠、羟丙基纤维素、甲基纤维素、乙基纤维素、明胶、蔗糖、聚乙烯吡咯烷酮；崩解剂为：羧甲基淀粉钠、干淀粉、低取代羟丙基纤维素、交联聚乙烯吡咯烷酮、交联羧甲基纤维素钠；润滑剂为：微粉硅胶、硬脂酸镁、滑石粉、氢化植物油、聚乙二醇类、月桂醇硫酸镁。
3、一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品的制备方法，其特征在于取蝙蝠蛾被毛孢菌丝，粉碎成极细粉，取极细粉333g，加入湿润剂和/或粘合剂30-40g、崩解剂20-30g，混合均匀，加入浓度10-15％的粘合剂溶液进行调和，制粒，80℃以下干燥，整粒，加入崩解剂25-35g，润滑剂10-20g、混匀，压制成1000片，包装，即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710015384A CN101095701B (zh) | 2007-07-15 | 2007-07-15 | 一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710015384A CN101095701B (zh) | 2007-07-15 | 2007-07-15 | 一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101095701A true CN101095701A (zh) | 2008-01-02 |
| CN101095701B CN101095701B (zh) | 2010-05-19 |
Family
ID=39009921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710015384A Active CN101095701B (zh) | 2007-07-15 | 2007-07-15 | 一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101095701B (zh) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240365A (zh) * | 2010-05-14 | 2011-11-16 | 湖南瑞丹科技有限公司 | 增强机体免疫力的药物组合物及其制备方法 |
| CN103127182A (zh) * | 2013-03-11 | 2013-06-05 | 王永铨 | 冬虫夏草真菌蝙蝠蛾被毛孢菌丝超细粉片剂的制备方法 |
| CN103432172A (zh) * | 2013-08-23 | 2013-12-11 | 周秋火 | 虫草片剂 |
| CN108065369A (zh) * | 2017-12-27 | 2018-05-25 | 青海珠峰冬虫夏草保健品有限公司 | 一种蝙蝠蛾被毛孢菌粉保健品 |
| CN109172617A (zh) * | 2018-11-29 | 2019-01-11 | 江西济民可信金水宝制药有限公司 | 一种口腔崩解片 |
| CN110496141A (zh) * | 2019-09-10 | 2019-11-26 | 杭州华东医药集团新药研究院有限公司 | 一种含冬虫夏草的药物组合物 |
| CN110575442A (zh) * | 2019-10-16 | 2019-12-17 | 青海珠峰冬虫夏草药业有限公司 | 一种发酵冬虫夏草菌粉片剂 |
| CN110772545A (zh) * | 2019-11-08 | 2020-02-11 | 西藏藏草宜生生物科技有限公司 | 一种蝙蝠蛾被毛孢菌丝超细粉的片剂的制备方法 |
| CN112617187A (zh) * | 2020-12-30 | 2021-04-09 | 广东粤微食用菌技术有限公司 | 一种具有增强免疫力功能的破壁蝙蝠蛾被毛孢菌丝体胶囊及其制备方法和用途 |
-
2007
- 2007-07-15 CN CN200710015384A patent/CN101095701B/zh active Active
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240365A (zh) * | 2010-05-14 | 2011-11-16 | 湖南瑞丹科技有限公司 | 增强机体免疫力的药物组合物及其制备方法 |
| CN103127182A (zh) * | 2013-03-11 | 2013-06-05 | 王永铨 | 冬虫夏草真菌蝙蝠蛾被毛孢菌丝超细粉片剂的制备方法 |
| CN103432172A (zh) * | 2013-08-23 | 2013-12-11 | 周秋火 | 虫草片剂 |
| CN108065369A (zh) * | 2017-12-27 | 2018-05-25 | 青海珠峰冬虫夏草保健品有限公司 | 一种蝙蝠蛾被毛孢菌粉保健品 |
| CN109172617A (zh) * | 2018-11-29 | 2019-01-11 | 江西济民可信金水宝制药有限公司 | 一种口腔崩解片 |
| CN110496141A (zh) * | 2019-09-10 | 2019-11-26 | 杭州华东医药集团新药研究院有限公司 | 一种含冬虫夏草的药物组合物 |
| CN110496141B (zh) * | 2019-09-10 | 2022-02-25 | 杭州华东医药集团新药研究院有限公司 | 一种含冬虫夏草的药物组合物 |
| CN110575442A (zh) * | 2019-10-16 | 2019-12-17 | 青海珠峰冬虫夏草药业有限公司 | 一种发酵冬虫夏草菌粉片剂 |
| CN110575442B (zh) * | 2019-10-16 | 2022-03-18 | 青海珠峰冬虫夏草药业有限公司 | 一种发酵冬虫夏草菌粉片剂 |
| CN110772545A (zh) * | 2019-11-08 | 2020-02-11 | 西藏藏草宜生生物科技有限公司 | 一种蝙蝠蛾被毛孢菌丝超细粉的片剂的制备方法 |
| CN112617187A (zh) * | 2020-12-30 | 2021-04-09 | 广东粤微食用菌技术有限公司 | 一种具有增强免疫力功能的破壁蝙蝠蛾被毛孢菌丝体胶囊及其制备方法和用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101095701B (zh) | 2010-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095701B (zh) | 一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的片状药品及其制备方法 | |
| CN104171204A (zh) | 一种调理大肠癌的茶 | |
| CN110882309A (zh) | 一种治疗鸡滑液囊支原体病的中药组合物及其制备方法 | |
| CN102258680A (zh) | 一种缓解体力疲劳的中药组合物及其制备方法和应用 | |
| CN100579536C (zh) | 一种含有蝙蝠蛾被毛孢-发酵虫草菌粉的颗粒状药品的制备方法 | |
| CN102145120B (zh) | 一种适于制备治疗ii型糖尿病的中药组合物 | |
| CN106511864A (zh) | 一种中药组合物及其制备方法和治疗宫颈癌的应用 | |
| CN102379990A (zh) | 一种治疗癌性疼痛的中药 | |
| CN109793855A (zh) | 一种用于治疗急性乳腺炎的中药制剂及其制备方法 | |
| CN103815406A (zh) | 一种灵芝孢子虫草组合物及其制备方法 | |
| CN107115295A (zh) | 一种含有冬虫夏草的液体组合物及其制备方法 | |
| CN105031290A (zh) | 一种复方铁皮石斛胶囊及其制备方法 | |
| CN104474327A (zh) | 一种治疗肺癌的中药组合物 | |
| CN104958342A (zh) | 一种金银花叶黄酮胶囊 | |
| CN109718304A (zh) | 改善人体心脑血管功能微循环及预防血栓的中药组合物 | |
| CN102614235A (zh) | 一种刺五加茶膏及其制备方法 | |
| CN100553668C (zh) | 一种微米糖参百仙铁皮石斛王养阴消疲酒制备方法 | |
| CN117562961A (zh) | 一种活血通脉胶囊 | |
| CN105998099A (zh) | 虫草含片及其制备方法 | |
| CN1733276A (zh) | 一种治疗消化不良的药物及其制备方法 | |
| CN107007739B (zh) | 改善或治疗放射性口咽黏膜炎的组合物及制备方法和应用 | |
| CN104147070B (zh) | 一种预防化疗性口腔炎症的药物组合物及其制备工艺 | |
| CN105125668A (zh) | 一种复方荷叶保健品及其制备方法 | |
| CN104306710A (zh) | 一种强心壮骨分散片及其制备方法 | |
| CN114681582A (zh) | 一种感冒口服中药组合物、制备方法及中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20161115 Address after: 264000 Shandong Province, Yantai District of Zhifu City Ring Road No. 88 Patentee after: Yantai Ruidong Technology Development Co. Ltd. Address before: 265500 Shandong city of Yantai province Fushan Fushan High-tech Zone Zhenzhong Street No. 298 Patentee before: Fan Li |
|
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 264000 Shandong Province, Yantai District of Zhifu City Ring Road No. 88 Patentee after: Sino US East (Yantai) Pharmaceutical Co., Ltd. Address before: 264000 Shandong Province, Yantai District of Zhifu City Ring Road No. 88 Patentee before: Yantai Ruidong Technology Development Co. Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 264000 Shandong Province, Yantai District of Zhifu City Ring Road No. 88 Patentee after: Huadong medicine (Yantai) Pharmaceutical Co., Ltd. Address before: 264000 Shandong Province, Yantai District of Zhifu City Ring Road No. 88 Patentee before: Sino US East (Yantai) Pharmaceutical Co., Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: No.88 Huanhai Road, Zhifu District, Yantai City, Shandong Province Patentee after: Yantai Huarui Pharmaceutical Co.,Ltd. Address before: No.88 Huanhai Road, Zhifu District, Yantai City, Shandong Province Patentee before: East China Pharmaceutical (Yantai) Pharmaceutical Co.,Ltd. |
|
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: 265500 No. 298, Zhenzhong street, Fushan District, Yantai City, Shandong Province Patentee after: Yantai Huarui Pharmaceutical Co.,Ltd. Address before: No.88 Huanhai Road, Zhifu District, Yantai City, Shandong Province Patentee before: Yantai Huarui Pharmaceutical Co.,Ltd. |